Literature DB >> 11742410

Diabetes mellitus and genetically programmed defects in beta-cell function.

G I Bell1, K S Polonsky.   

Abstract

The pathways that control insulin secretion and regulate pancreatic beta-cell mass are crucial in the development of diabetes mellitus. Maturity-onset diabetes of the young comprises a number of single-gene disorders affecting pancreatic beta-cell function, and the consequences of mutations in these genes are so serious that diabetes develops in childhood or adolescence. A genetic basis for the more common form of type 2 diabetes, which affects 10-20% of adults in many developed countries, is less clear cut. It is also characterized by abnormal beta-cell function, but other tissues are involved as well. However, in both forms identification of causative and susceptibility genes are providing new insight into the control of insulin action and secretion, as well as suggesting new treatments for diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742410     DOI: 10.1038/414788a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  151 in total

1.  Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor.

Authors:  Shouhong Xuan; Tadahiro Kitamura; Jun Nakae; Katerina Politi; Yoshiaki Kido; Peter E Fisher; Manrico Morroni; Saverio Cinti; Morris F White; Pedro L Herrera; Domenico Accili; Argiris Efstratiadis
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Control of pancreas and liver gene expression by HNF transcription factors.

Authors:  Duncan T Odom; Nora Zizlsperger; D Benjamin Gordon; George W Bell; Nicola J Rinaldi; Heather L Murray; Tom L Volkert; Jörg Schreiber; P Alexander Rolfe; David K Gifford; Ernest Fraenkel; Graeme I Bell; Richard A Young
Journal:  Science       Date:  2004-02-27       Impact factor: 47.728

Review 4.  Nanospaces between endoplasmic reticulum and mitochondria as control centres of pancreatic β-cell metabolism and survival.

Authors:  James D Johnson; Michael J Bround; Sarah A White; Dan S Luciani
Journal:  Protoplasma       Date:  2011-11-22       Impact factor: 3.356

Review 5.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

Review 6.  Protein phosphatases in pancreatic islets.

Authors:  Henrik Ortsäter; Nina Grankvist; Richard E Honkanen; Åke Sjöholm
Journal:  J Endocrinol       Date:  2014-03-28       Impact factor: 4.286

7.  Pancreatic islet immunoreactivity to the Reg protein INGAP.

Authors:  David A Taylor-Fishwick; Angela Bowman; Maricarmen Korngiebel-Rosique; Aaron I Vinik
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

8.  In Vitro Platform for Studying Human Insulin Release Dynamics of Single Pancreatic Islet Microtissues at High Resolution.

Authors:  Patrick M Misun; Burçak Yesildag; Felix Forschler; Aparna Neelakandhan; Nassim Rousset; Adelinn Biernath; Andreas Hierlemann; Olivier Frey
Journal:  Adv Biosyst       Date:  2020-01-29

9.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 10.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.